Axsome Therapeutics, Inc. (AXSM) SEC filings
AXSM SEC filings moved a median of +0.31% by the close. AXSM SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AXSM overview →
68 measured AXSM SEC filing events.
Where these AXSM SEC filings landedvs 67 measured AXSM SEC filing reactions
| Middle 50% of AXSM SEC filing reactions | -1.22% to +2.35% |
|---|---|
| Median reaction (to close) | +0.31% |
| Measured reactions | 67 |
Point-in-time · zero look-ahead
Half of the 67 AXSM SEC filing events with a measured close landed between -1.22% and +2.35%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Axsome Therapeutics, For: Aug 10 | SEC filing · Form 8-K | -0.23% | — | |
| Form 8-K Axsome Therapeutics, For: Jul 15 | SEC filing · Form 8-K | -0.80% | +2.13% | |
| Form 8-K Axsome Therapeutics, For: Jun 05 | SEC filing · Form 8-K | +1.15% | +0.07% | |
| Form 8-K Axsome Therapeutics, For: Jun 03 | SEC filing · Form 8-K | -2.00% | +3.68% | |
| Form 10-Q Axsome Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.33% | -0.86% | |
| Form 8-K Axsome Therapeutics, For: May 04 | SEC filing · Form 8-K | +5.90% | +7.29% | |
| Form 8-K Axsome Therapeutics, For: Apr 30 | SEC filing · Form 8-K | -1.34% | -0.59% | |
| Form ARS Axsome Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.42% | +0.48% | |
| Form DEF 14A Axsome Therapeutics, For: Apr 24 | SEC filing · Form DEF | +1.42% | +0.48% | |
| Form DEFA14A Axsome Therapeutics, | SEC filing · Form DEFA14A | +1.42% | +0.48% | |
| Form 8-K Axsome Therapeutics, For: Apr 01 | SEC filing · Form 8-K | +1.77% | +0.76% | |
| Form 10-K Axsome Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.55% | -2.74% | |
| Form 8-K Axsome Therapeutics, For: Feb 23 | SEC filing · Form 8-K | +2.31% | +0.59% | |
| Form 8-K Axsome Therapeutics, For: Feb 17 | SEC filing · Form 8-K | -1.15% | -0.19% | |
| Form 8-K Axsome Therapeutics, For: Jan 12 | SEC filing · Form 8-K | -0.00% | +2.50% | |
| Form 8-K Axsome Therapeutics, For: Dec 31 | SEC filing · Form 8-K | +3.91% | +15.24% | |
| Form 10-Q Axsome Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.33% | +0.69% | |
| Form 8-K Axsome Therapeutics, For: Nov 03 | SEC filing · Form 8-K | +1.16% | +9.56% | |
| Form S-3ASR Axsome Therapeutics, | SEC filing · Form S-3ASR | -0.33% | +0.69% | |
| Form 8-K Axsome Therapeutics, For: Aug 19 | SEC filing · Form 8-K | -1.28% | +0.13% | |
| Form S-8 Axsome Therapeutics, | SEC filing · Form S-8 | +0.35% | +0.06% | |
| Form 10-Q Axsome Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.11% | -2.38% | |
| Form 8-K Axsome Therapeutics, For: Aug 04 | SEC filing · Form 8-K | -3.19% | -1.35% | |
| Form 8-K Axsome Therapeutics, For: Jun 10 | SEC filing · Form 8-K | +1.37% | -0.19% | |
| Form 8-K Axsome Therapeutics, For: Jun 06 | SEC filing · Form 8-K | +1.37% | -0.19% | |
| Form 8-K Axsome Therapeutics, For: Jun 09 | SEC filing · Form 8-K | +0.29% | -0.57% | |
| Form 8-K Axsome Therapeutics, For: May 27 | SEC filing · Form 8-K | -0.89% | -2.60% | |
| Form 8-K Axsome Therapeutics, For: May 08 | SEC filing · Form 8-K | -1.01% | -4.03% | |
| Form 10-Q Axsome Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.14% | -3.11% | |
| Form 8-K Axsome Therapeutics, For: May 05 | SEC filing · Form 8-K | +2.47% | +2.11% | |
| Form ARS Axsome Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.95% | +0.31% | |
| Form DEF 14A Axsome Therapeutics, For: Apr 25 | SEC filing · Form DEF | +1.95% | +0.31% | |
| Form DEFA14A Axsome Therapeutics, | SEC filing · Form DEFA14A | +1.95% | +0.31% | |
| Form 8-K Axsome Therapeutics, For: Apr 01 | SEC filing · Form 8-K | -1.54% | -0.68% | |
| Form 8-K Axsome Therapeutics, For: Mar 25 | SEC filing · Form 8-K | -1.06% | -7.18% | |
| Form 8-K Axsome Therapeutics, For: Mar 05 | SEC filing · Form 8-K | +0.83% | -0.37% | |
| Form 8-K Axsome Therapeutics, For: Mar 03 | SEC filing · Form 8-K | -0.32% | -2.19% | |
| Form 10-K Axsome Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.21% | -1.44% | |
| Form 8-K Axsome Therapeutics, For: Feb 18 | SEC filing · Form 8-K | +3.30% | +2.75% | |
| Form 8-K Axsome Therapeutics, For: Feb 10 | SEC filing · Form 8-K | -0.96% | +3.38% | |
| Form 8-K Axsome Therapeutics, For: Jan 30 | SEC filing · Form 8-K | -2.14% | -3.02% | |
| Form 8-K Axsome Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -0.83% | +8.54% | |
| Form 8-K Axsome Therapeutics, For: Dec 30 | SEC filing · Form 8-K | -0.41% | +3.39% | |
| Form 8-K Axsome Therapeutics, For: Nov 26 | SEC filing · Form 8-K | +0.01% | -0.48% | |
| Form 10-Q Axsome Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.95% | +3.42% | |
| Form 8-K Axsome Therapeutics, For: Nov 12 | SEC filing · Form 8-K | -0.51% | +6.50% | |
| Form 8-K Axsome Therapeutics, For: Sep 30 | SEC filing · Form 8-K | +0.31% | +3.58% | |
| Form 8-K Axsome Therapeutics, For: Sep 04 | SEC filing · Form 8-K | -0.47% | +6.59% | |
| Form 8-K Axsome Therapeutics, For: Aug 21 | SEC filing · Form 8-K | -0.31% | -0.67% | |
| Form 10-Q Axsome Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.01% | +0.97% | |
| Form 8-K Axsome Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +2.39% | +13.60% | |
| Form S-8 Axsome Therapeutics, | SEC filing · Form S-8 | +1.01% | +0.97% | |
| Form 8-K Axsome Therapeutics, For: Jun 07 | SEC filing · Form 8-K | -1.41% | -1.69% | |
| Form 8-K Axsome Therapeutics, For: Jun 05 | SEC filing · Form 8-K | -0.56% | +1.38% | |
| Form 10-Q Axsome Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.44% | +1.80% | |
| Form 8-K Axsome Therapeutics, For: May 06 | SEC filing · Form 8-K | -0.19% | +1.25% | |
| Form ARS Axsome Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.56% | -1.33% | |
| Form DEF 14A Axsome Therapeutics, For: Apr 26 | SEC filing · Form DEF | +0.56% | -1.33% | |
| Form 8-K Axsome Therapeutics, For: Mar 28 | SEC filing · Form 8-K | -3.75% | -3.52% | |
| Form 8-K Axsome Therapeutics, For: Mar 25 | SEC filing · Form 8-K | -0.74% | -7.25% | |
| Form 8-K Axsome Therapeutics, For: Mar 19 | SEC filing · Form 8-K | +2.19% | +5.08% | |
| Form 10-K Axsome Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.27% | -2.08% | |
| Form 8-K Axsome Therapeutics, For: Feb 20 | SEC filing · Form 8-K | +1.76% | -4.54% | |
| Form 8-K Axsome Therapeutics, For: Jan 08 | SEC filing · Form 8-K | +0.91% | +6.21% | |
| Form 8-K Axsome Therapeutics, For: Jan 04 | SEC filing · Form 8-K | -0.15% | +5.02% | |
| Form 8-K Axsome Therapeutics, For: Dec 07 | SEC filing · Form 8-K | -1.37% | -1.11% | |
| Form 10-Q Axsome Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.50% | +2.20% | |
| Form 8-K Axsome Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +2.87% | +1.84% |
Keep exploring
More AXSM: earnings → · analyst actions → · AXSM overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Rubius Therapeutics, Inc. (RUBY) | 392 | -0.32% | 45% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 391 | +0.13% | 52% |
| RA PHARMACEUTICALS (RARX) | 391 | -0.04% | 45% |
| Checkpoint Therapeutics, Inc. (CKPT) | 389 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.